Le Ribeuz, H., Courboulin, A., Ghigna, M., Lambert, M., Hautefort, A., Humbert, M., . . . Antigny, F. (2020). In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression. Respir Res.
Chicago Stili AlıntıLe Ribeuz, Hélène, et al. "In Vivo MiR-138-5p Inhibition Alleviates Monocrotaline-induced Pulmonary Hypertension and Normalizes Pulmonary KCNK3 and SLC45A3 Expression." Respir Res 2020.
MLA AlıntıLe Ribeuz, Hélène, et al. "In Vivo MiR-138-5p Inhibition Alleviates Monocrotaline-induced Pulmonary Hypertension and Normalizes Pulmonary KCNK3 and SLC45A3 Expression." Respir Res 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..